Achievements
-
.>90%of severe malaria cases
now treated with injectable artesunate in preference to quinine across 6 countries through the MMV-led ISMO project
-
.73mcourses of SP+AQ
were shipped to countries in West Africa's Sahel region in 2016, by MMV's partner Guilin Pharmaceutical, enough to provide 18 million children with Seasonal Malaria Chemoprevention
-
.100mvials
of Artesun® (Guilin Pharma's injectable artesunate) delivered to treat children with severe malaria, saving an estimated additional 650,000 lives compared to quinine treatment
Defeating malaria together
Featured resources
Events
-
21May
16th International Pharmaceutical Microbiology and Biotechnology Conference
21 - 23 MayVienna, Austria -
23May
Every Child, Everywhere: Leveraging Innovation for Child-friendly Medicines for Poverty-related and Neglected Tropical Diseases
23 May 2018Geneva, Switzerland -
06Jun
Pharmaceutical Contract Management Group Annual Conference 2018
6 - 8 June 2018Valetta, Malta